RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biolight Life Sciences Stock

Biolight Life Sciences Net Income 2024

Biolight Life Sciences Net Income

-26.02 M ILS

Ticker

BOLT.TA

ISIN

IL0010952237

In 2024, Biolight Life Sciences's profit amounted to -26.02 M ILS, a 231.59% increase from the -7.85 M ILS profit recorded in the previous year.

The Biolight Life Sciences Net Income history

YEARNET INCOME (undefined ILS)
2023-26.02
2022-7.85
20210.38
2020-13.38
2019-12.59
201865.39
2017-17.26
2016-21.82
2015-19.26
2014-23.1
2013-18.84
2012-12.73
2011-1.81
2010-19.51
2009-25.43
2008-18.34
2007-32.61
2006-27.5
2005-1.99

Biolight Life Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Biolight Life Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biolight Life Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biolight Life Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Biolight Life Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Biolight Life Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Biolight Life Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biolight Life Sciences’s growth potential.

Biolight Life Sciences Revenue, EBIT and net profit per share

DateBiolight Life Sciences RevenueBiolight Life Sciences EBITBiolight Life Sciences Net Income
2023118,000 ILS-10.65 M ILS-26.02 M ILS
202263,000 ILS-10.32 M ILS-7.85 M ILS
20213,000 ILS-10.6 M ILS382,000 ILS
202031,000 ILS-11.33 M ILS-13.38 M ILS
2019297,000 ILS-14.02 M ILS-12.59 M ILS
20183.69 M ILS53.95 M ILS65.39 M ILS
20171.21 M ILS-26.88 M ILS-17.26 M ILS
20162.11 M ILS-30.4 M ILS-21.82 M ILS
20151.39 M ILS-26.56 M ILS-19.26 M ILS
2014941,000 ILS-33.61 M ILS-23.1 M ILS
201380,000 ILS-28.44 M ILS-18.84 M ILS
2012790,000 ILS-9.52 M ILS-12.73 M ILS
201150,000 ILS-12.4 M ILS-1.81 M ILS
20100 ILS-21.81 M ILS-19.51 M ILS
20090 ILS-24.96 M ILS-25.43 M ILS
20080 ILS-19.67 M ILS-18.34 M ILS
20070 ILS-29.11 M ILS-32.61 M ILS
20060 ILS-24.02 M ILS-27.5 M ILS
20050 ILS-2.03 M ILS-1.99 M ILS

Biolight Life Sciences stock margins

The Biolight Life Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biolight Life Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biolight Life Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Biolight Life Sciences's sales revenue. A higher gross margin percentage indicates that the Biolight Life Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Biolight Life Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Biolight Life Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biolight Life Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biolight Life Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biolight Life Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Biolight Life Sciences Margin History

Biolight Life Sciences Gross marginBiolight Life Sciences Profit marginBiolight Life Sciences EBIT marginBiolight Life Sciences Profit margin
2023100 %-9,026.27 %-22,050.85 %
2022100 %-16,384.13 %-12,455.56 %
2021100 %-353,433.33 %12,733.33 %
2020100 %-36,541.94 %-43,167.74 %
201969.7 %-4,719.87 %-4,239.39 %
201820.61 %1,463.33 %1,773.39 %
201737.22 %-2,223.16 %-1,427.63 %
201652.82 %-1,440.17 %-1,033.82 %
201547.23 %-1,909.2 %-1,384.54 %
201442.83 %-3,571.31 %-2,455.05 %
201375 %-35,550 %-23,550 %
2012100 %-1,205.06 %-1,611.39 %
2011100 %-24,800 %-3,620 %
2010100 %0 %0 %
2009100 %0 %0 %
2008100 %0 %0 %
2007100 %0 %0 %
2006100 %0 %0 %
2005100 %0 %0 %

Biolight Life Sciences Aktienanalyse

What does Biolight Life Sciences do?

Biolight Life Sciences Ltd is a global company specializing in the development, production, and marketing of medical devices and products. It was founded in China in 1993 and has since relocated its headquarters to Israel. Biolight has evolved from a small company to a leading provider of medical devices and products that help improve patient treatment and optimize healthcare. The company's business model is based on selling medical devices and products used in diagnosis, monitoring, and treatment of patients. It continually strives to improve its products through research and development to enhance healthcare worldwide. Biolight believes that cooperative technologies and services can create synergistic value that benefits patients. Its various divisions include monitoring and diagnostic devices, cardiology products, and emergency medicine products. Biolight offers a wide range of products to ensure quality healthcare. Its monitoring and diagnostic devices measure various physiological parameters such as blood pressure, heart rate, respiration, oxygen saturation, and temperature. The cardiology products are tailored to the needs of heart patients and include EKG devices, long-term EKG systems, and Holter devices. The emergency medicine products treat life-threatening conditions such as heart attacks, strokes, and respiratory distress, thereby saving lives. To ensure a high-quality healthcare system, it is essential for medical devices and products to meet the highest standards. Biolight is aware of this and is committed to offering products that comply with the strictest international quality standards such as ISO 13485, CE, and FDA. Biolight has a broad global presence with branches and subsidiaries in numerous countries such as the USA, China, India, Germany, Spain, and France. This global presence enables the company to understand and meet the needs of patients and medical personnel in different parts of the world. Biolight also collaborates with partners and customers to further improve its products and services and meet market demands. Overall, Biolight has made a sustainable contribution to improving healthcare. Through its continuous research and development, products and services, and global presence, the company has established itself as a key player in the medical technology industry. By working with partners and customers, Biolight can contribute to ensuring that patients worldwide have access to the best healthcare. Biolight Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Biolight Life Sciences's Profit Margins

The profit margins of Biolight Life Sciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Biolight Life Sciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Biolight Life Sciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Biolight Life Sciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Biolight Life Sciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Biolight Life Sciences stock

How much profit has Biolight Life Sciences made this year?

Biolight Life Sciences has made -26.02 M ILS this year.

How has the profit developed compared to last year?

The profit has increased by 231.59% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Biolight Life Sciences publish its earnings?

Biolight Life Sciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Biolight Life Sciences?

The profits of Biolight Life Sciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Biolight Life Sciences?

You can learn more about the earnings of Biolight Life Sciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Biolight Life Sciences pay?

Over the past 12 months, Biolight Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biolight Life Sciences is expected to pay a dividend of 0 ILS.

What is the dividend yield of Biolight Life Sciences?

The current dividend yield of Biolight Life Sciences is .

When does Biolight Life Sciences pay dividends?

Biolight Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biolight Life Sciences?

Biolight Life Sciences paid dividends every year for the past 0 years.

What is the dividend of Biolight Life Sciences?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biolight Life Sciences located?

Biolight Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biolight Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biolight Life Sciences from 10/3/2024 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Biolight Life Sciences pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Biolight Life Sciences in the year 2023?

In the year 2023, Biolight Life Sciences distributed 0 ILS as dividends.

In which currency does Biolight Life Sciences pay out the dividend?

The dividends of Biolight Life Sciences are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biolight Life Sciences

Our stock analysis for Biolight Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biolight Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.